RCS - Arxada AG - Arxada extends partnership with DSM

FTI ConsultingAnnouncement

24/08/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220824:nRSX0407Xa&default-theme=true

RNS Number : 0407X  Arxada AG  24 August 2022

Arxada extends partnership with DSM and invests in Visp, Switzerland, facility

 

·      Arxada to invest CHF 20m in the growth of the Visp facility and
commits to reducing the site's carbon footprint

 

Basel, Switzerland - 24 August 2022 - Arxada, a global leader in specialty
chemicals, today announces the extension of its long-term collaboration with
Royal DSM (DSM), a global science-based company, for the supply of niacin and
a range of other nutritional ingredients from Arxada's facility in Visp,
Switzerland, to DSM's vitamin and aroma ingredients business in neighboring
Visp-Lalden.

 

As part of this long-term partnership extension with DSM, Arxada will invest
CHF 20m in its world-class production facility in Visp. This investment will
be used to expand production lines at the site and increase Arxada's output of
nutritional ingredients supplied to DSM.

 

Arxada will also make further investments to reduce the carbon footprint of
the Visp site to help meet the sustainability commitments of both companies.
This follows Arxada's significant investment in Visp in 2021 to reduce other
greenhouse gas emissions at the site.

 

Antje Gerber, President, Specialty Products Solutions, Arxada, said:

"We are delighted to be extending our agreement with DSM and building on the
longstanding, mutually beneficial partnership with our neighbors in the Swiss
Valais canton. This significant new investment in our Visp facility secures
the site's long-term future, helping to fuel our future growth, and
demonstrates our clear commitment to sustainability and reducing our carbon
footprint."

 

 

- ENDS -

 

Media Enquiries

 Arxada                                                                      FTI Consulting

 Birgit Gronkowski                                                           Rob Winder/Amy Byrne

 Head of Communications                                                      Tel: +44 20 3727 1000

 Tel: +41 61 316 8111                                                        Email: Arxada@fticonsulting.com (mailto:Arxada@fticonsulting.com)

 Email: birgit.gronkowski@arxada.com (mailto:birgit.gronkowski@arxada.com)

 

About Arxada

Arxada is a global specialty chemicals business with a world-class offering in
Consumer Microbial Control (CMC), Industrial Microbial Control (IMC) and
Specialty Products Solutions (SPS). Arxada provides a broad portfolio of
differentiated products targeted at a range of end markets, supported by its
leading regulatory capabilities, IP expertise and established track record in
R&D.

 

Arxada's CMC business targets five end markets: Hygiene, Home and Personal
Care, Wood Protection, Crop Protection, and Food, Beverage and Water, while
IMC focuses on Paints and Coatings and Material Protection. Both businesses
build on superior regulatory expertise, the broadest set of antimicrobial
agents and the widest range of registrations in the world, which are critical
to maintaining the integrity of their customers' products.

 

SPS provides complex, high-quality technologies and chemistries to customers
across a range of industries within its three business lines: Performance
Intermediates and Chemicals, Composite Materials and the Custom Development
and Manufacturing Organization.

 

The three businesses work closely together to provide complementary expertise
and deliver unique, innovative solutions to help customers protect their
products from harmful microorganisms, improve health and safety and reduce
their environmental footprints.

 

Arxada has a global footprint spanning 26 production sites and 17 R&D
centers, with a world-leading team of 3,800 employees serving customers across
a wide range of industries.

 

Arxada, formerly part of Lonza Group, is owned by Bain Capital Private Equity
and Cinven.

 

To learn more about Arxada, please visit: arxada.com (https://www.arxada.com/)
and Arxada on LinkedIn (https://www.linkedin.com/company/arxada/) .

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEZLBLLVLEBBX